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LETTERS TO THE EDITOR
To the Editor:
We read with great interest the article on the genetic
susceptibility to atrial fibrillation (AF) in patients with con-
gestive heart failure by Bedi et al1 in the July 2006 issue of
Heart Rhythm.
The authors examined the role of angiotensin-converting
enzyme (ACE) I/D and endothelial nitric oxide synthase
(eNOS) polymorphisms in predisposing to AF and specu-
late, in particular, on the role of the eNOS 894 G wild-type
allele in affecting this predisposition.
We have a comment on the emphasis on the role of the
eNOS G894T polymorphism in predisposing to AF. In reading
carefully the results in both the abstract and the text, we noticed
a conflictual finding. In the abstract, a significant association
between eNOS 894 T/T genotype (odds ratio 3.2) and AF is
reported. On the contrary, in the Results section, the same odds
ratio is referred to the homozygosity for the eNOS 894 G
wild-type allele. Thus, the role of the 894 G/G genotype as a
predisposing factor to AF is reported in the Results section,
whereas the role of the eNOS T rare allele as a predisposing
factor to the disease is discussed. These divergent data confuse
the reading and the interpretation of results.
Studies in the literature reported that the 894 T rare allele
is associated with reduced basal nitric oxide production,2
even if this functional role still is a matter of debate.3 In
particular, experimental data demonstrated that nitric oxide
enhances cardiac vagal activity and participates in the inhi-
bition of sympathetic activity.4 Moreover, eNOS regulates
the L-type calcium channel and modulates myocyte con-
tractility. The L-type calcium channel is essential for normal
sinus function, and nitric oxide, by stimulating the forma-
tion of cGMP, which affects this channel, might play a role
in suppressing arrhythmias through a cGMP-mediated path-
way. A decrease in nitric oxide levels, related to the pres-
ence of the eNOS 894 T variant, might contribute to mod-
ulation of AF through an increase in L-type calcium current.
Normal availability of nitric oxide, related to the presence of
eNOS 894 G wild-type allele, could contribute to mainte-
nance of normal sinus function.
Finally, the authors state that their findings are at variance
with those from our group.5 In actuality, the results are com-
pletely in agreement with ours, demonstrating no association
between the eNOS 894 T/T genotype and predisposition to AF.
In consideration of our comment, we do not believe that
the conclusions stated by Bedi et al (i.e., that the eNOS 894
T/T genotype is significantly associated with AF) can be
drawn from this study.
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To The Editor—Response:
We appreciate the letter from Dr. Fatini regarding the
detection of an error in our recent publication in Heart
Rhythm.1 The error is typographical in nature and is located
in the abstract, in which T/T (characterizing homozygous
thymine replacement of guanine at position 894 of exonic
segment 7 of the eNOS gene2) appears rather than that
which we had intended, G/G (characterizing homozygous
guanine in this position). In the text of the article, the data
presented and the subsequent discussion are consistent in
associating the G allele (in particular the G/G genotype), not
the T allele, with the presence of atrial fibrillation (AF). As
we intimate in the discussion, this finding was counterintui-
tive based on prior reports (cited), which suggest that the G
allele should not be associated with an increased propensity to
AF. Although we could have deduced a protective (anti-AF)
effect for the T allele from our data, we decided to conclude
that although there appears to be a relationship between poly-
morphism at position 894 and AF, its nature remains obscure.
We are embarrassed by the error and sincerely apologize
to the readership for any confusion arising from it.2
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